Royal Bank Of Canada Zentalis Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 26,911 shares of ZNTL stock, worth $60,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,911

Previous 6,845 293.15%

Holding current value

$60,011

Previous $25,000 224.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.7 - $4.03 $54,178 - $80,865	20,066 Added 293.15%	26,911 $81,000
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $2,740 - $4,318	945 Added 16.02%	6,845 $25,000
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $12,343 - $48,680	3,018 Added 104.72%	5,900 $24,000
Q1 2024 Nov 05, 2024	SELL	$10.83 - $16.49 $32,684 - $49,766	-3,018 Reduced 51.15%	2,882 $45,000
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $158,605 - $241,496	-14,645 Reduced 83.56%	2,882 $45,000
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $97,199 - $198,844	9,878 Added 129.14%	17,527 $265,000
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $85,449 - $123,146	4,353 Added 132.07%	7,649 $153,000
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $10,707 - $18,480	615 Added 22.94%	3,296 $92,000
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $84,718 - $130,910	-5,249 Reduced 66.19%	2,681 $46,000
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $132,507 - $187,724	7,333 Added 1228.31%	7,930 $159,000
Q3 2022 Nov 14, 2022	SELL	$20.23 - $31.73 $282,329 - $442,823	-13,956 Reduced 95.9%	597 $13,000
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $35,694 - $104,134	-1,993 Reduced 12.05%	14,553 $409,000
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $263,908 - $513,408	-6,347 Reduced 27.72%	16,546 $763,000
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $1.3 Million - $1.65 Million	19,439 Added 562.8%	22,893 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $55,165 - $86,583	1,178 Added 51.76%	3,454 $230,000
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $85,145 - $141,681	2,276 New	2,276 $121,000

Others Institutions Holding ZNTL

# of Institutions

147

Shares Held

65.3M

Call Options Held

43.2K

Put Options Held

21.7K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $127M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Zentalis Pharmaceuticals, Inc. Transaction History